Transcranial Magnetic Stimulation for Word-Finding Difficulty
(CSST Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether Transcranial Magnetic Stimulation (TMS) can assist with word-finding difficulties. TMS, a non-invasive technique, uses magnetic fields to stimulate specific brain areas, focusing on the left anterior temporal lobe, crucial for word processing. The trial aims to observe how this brain region activates during word recall. It seeks native English speakers who are right-handed and have no history of conditions like dementia or brain injuries. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could enhance understanding of brain function and language processing.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators.
What prior data suggests that Transcranial Magnetic Stimulation is safe for word-finding difficulty?
Studies have shown that Transcranial Magnetic Stimulation (TMS) is generally safe. Specifically, research indicates that the type of TMS used in this trial, involving a single pulse, is safe when used correctly. No evidence suggests that this type of TMS increases the risk of seizures when the intensity is carefully managed.
Most studies focus on repetitive TMS (rTMS), which uses multiple pulses, but these findings still reassure those using single-pulse TMS. People using TMS for speech problems, such as difficulty finding words, have shown improvements without major side effects. Overall, TMS is considered a safe option for many patients.12345Why are researchers excited about this trial?
Transcranial Magnetic Stimulation (TMS) is unique because it uses magnetic fields to stimulate nerve cells in the brain, which is a different approach from the medications and speech therapies typically used for word-finding difficulties. Researchers are excited about TMS because it offers a non-invasive, painless method that targets specific brain areas involved in language processing. Unlike traditional treatments that can take weeks or months to show improvements, TMS has the potential to produce quicker results, providing faster relief for individuals struggling with language issues.
What evidence suggests that Transcranial Magnetic Stimulation is effective for word-finding difficulty?
Studies have shown that Transcranial Magnetic Stimulation (TMS) can assist with language difficulties, such as trouble finding the right words. In some research, participants who received TMS spoke more clearly and named objects more easily. Another study found that TMS enabled people to speak in longer sentences with fewer pauses. These results suggest that TMS might activate brain areas important for language. This trial will specifically investigate the effects of single-pulse TMS on word-finding difficulties. Although direct evidence for single-pulse TMS is limited, promising data suggest it could effectively improve these difficulties.24678
Are You a Good Fit for This Trial?
This trial is for native English speakers aged 18 to 40 who have difficulty finding words. It's not suitable for left-handed individuals, those with dementia, alcohol abuse, psychiatric or neurological disorders, traumatic brain injury, or severe vision/hearing issues that could affect task performance.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo a structural MRI scan for TMS target localization
TMS and Task Performance
Participants perform lexical, semantic, and number judgment tasks with TMS applied at different time points
Follow-up
Participants are monitored for any delayed effects of TMS and data analysis is conducted
What Are the Treatments Tested in This Trial?
Interventions
- Single-pulse TMS
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Carolina
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator